PMA supplement
P910073 S091: ENDOTAK RELIANCE IS-I PASSIVE FIXATION
FDA PMA supplement · Normal 180 Day Track · Boston Scientific
Key facts
| Original PMA | P910073 |
|---|---|
| Supplement number | S091 |
| Supplement type | Normal 180 Day Track |
| Reason for the supplement | Change Design/Components/Specifications/Material |
| Trade name | ENDOTAK RELIANCE IS-I PASSIVE FIXATION |
| Generic name | Permanent defibrillator electrodes |
| Applicant | Boston Scientific |
| Product code | NVY |
| Received date | Dec 14, 2010 |
| Decision date | Jan 5, 2012 |
At a glance
- No Expedited review granted
- Yes Approval order on file
- No Summary of safety and effectiveness on file
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMA supplements
A PMA supplement asks FDA to approve a change to a device that already holds a premarket approval: a new indication, a design or labeling change, a manufacturing site or process change.
Source: U.S. Food and Drug Administration (FDA), Premarket Approval (PMA) database · Source date: